Institution
Mater Dei Hospital
Healthcare•Imsida, Malta•
About: Mater Dei Hospital is a healthcare organization based out in Imsida, Malta. It is known for research contribution in the topics: Population & Medicine. The organization has 1055 authors who have published 1433 publications receiving 19034 citations.
Papers published on a yearly basis
Papers
More filters
••
Dresden University of Technology1, Royal Perth Hospital2, Trinity College, Dublin3, University of the West Indies4, Mater Dei Hospital5, The Chinese University of Hong Kong6, Friedrich Loeffler Institute7, Health Protection Agency8, University of Lyon9, Curtin University10, Shaikh Khalifa Medical City11
TL;DR: A high level of biodiversity among MRSA, especially among strains harbouring SCCmec IV and V elements is shown, and the data indicate a high rate of genetic recombination in MRSA involving SCC elements, bacteriophages or other mobile genetic elements and large-scale chromosomal replacements.
Abstract: In recent years, methicillin-resistant Staphylococcus aureus (MRSA) have become a truly global challenge. In addition to the long-known healthcare-associated clones, novel strains have also emerged outside of the hospital settings, in the community as well as in livestock. The emergence and spread of virulent clones expressing Panton-Valentine leukocidin (PVL) is an additional cause for concern. In order to provide an overview of pandemic, epidemic and sporadic strains, more than 3,000 clinical and veterinary isolates of MRSA mainly from Germany, the United Kingdom, Ireland, France, Malta, Abu Dhabi, Hong Kong, Australia, Trinidad & Tobago as well as some reference strains from the United States have been genotyped by DNA microarray analysis. This technique allowed the assignment of the MRSA isolates to 34 distinct lineages which can be clearly defined based on non-mobile genes. The results were in accordance with data from multilocus sequence typing. More than 100 different strains were distinguished based on affiliation to these lineages, SCCmec type and the presence or absence of PVL. These strains are described here mainly with regard to clinically relevant antimicrobial resistance- and virulence-associated markers, but also in relation to epidemiology and geographic distribution. The findings of the study show a high level of biodiversity among MRSA, especially among strains harbouring SCCmec IV and V elements. The data also indicate a high rate of genetic recombination in MRSA involving SCC elements, bacteriophages or other mobile genetic elements and large-scale chromosomal replacements.
834 citations
••
University of Rome Tor Vergata1, University of Alberta2, University of Lisbon3, Frederiksberg Hospital4, University of Naples Federico II5, Sheba Medical Center6, Mater Dei Hospital7, Royal London Hospital8, University College London9, The Catholic University of America10, Sapienza University of Rome11, Pennine Acute Hospitals NHS Trust12, Cleveland Clinic13, University of Barcelona14, St James's University Hospital15, University Medical Center Groningen16, Katholieke Universiteit Leuven17, University of Amsterdam18
TL;DR: Christian Maaser, a Andreas Sturm,b Stephan R. Vavricka,c Torsten Kucharzik,d Gionata Fiorino,e Vito Annese,f Emma Calabrese,f Daniel C. Baumgart,h Dominik Bettenworth,i Paula Borralho Nunes,j, Johan Burisch,k, Fabiana Castiglione,l Rami Eliakim,m Pierre Ellul,n Yago Gonz
Abstract: Christian Maaser,a Andreas Sturm,b Stephan R. Vavricka,c Torsten Kucharzik,d Gionata Fiorino,e Vito Annese,f Emma Calabrese,g Daniel C. Baumgart,h Dominik Bettenworth,i Paula Borralho Nunes,j, Johan Burisch,k, Fabiana Castiglione,l Rami Eliakim,m Pierre Ellul,n Yago González-Lama,o Hannah Gordon,p Steve Halligan,q Konstantinos Katsanos,r Uri Kopylov,m Paulo G. Kotze,s Eduards Krustiņš,t Andrea Laghi,u Jimmy K. Limdi,v Florian Rieder,w Jordi Rimola,x Stuart A. Taylor,y Damian Tolan,z Patrick van Rheenen,aa Bram Verstockt,bb, Jaap Stokercc; on behalf of the European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]
779 citations
••
TL;DR: A standardised methodology for a combined point prevalence survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals developed by the European Centre for Disease Prevention and Control was piloted across Europe.
Abstract: A standardised methodology for a combined point prevalence survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals developed by the European Centre for Disease Prevention and Control was piloted across Europe. Variables were collected at national, hospital and patient level in 66 hospitals from 23 countries. A patient-based and a unit-based protocol were available. Feasibility was assessed via national and hospital questionnaires. Of 19,888 surveyed patients, 7.1% had an HAI and 34.6% were receiving at least one antimicrobial agent. Prevalence results were highest in intensive care units, with 28.1% patients with HAI, and 61.4% patients with antimicrobial use. Pneumonia and other lower respiratory tract infections (2.0% of patients; 95% confidence interval (CI): 1.8–2.2%) represented the most common type (25.7%) of HAI. Surgical prophylaxis was the indication for 17.3% of used antimicrobials and exceeded one day in 60.7% of cases. Risk factors in the patient-based protocol were provided for 98% or more of the included patients and all were independently associated with both presence of HAI and receiving an antimicrobial agent. The patient-based protocol required more work than the unit-based protocol, but allowed collecting detailed data and analysis of risk factors for HAI and antimicrobial use.
646 citations
••
University of Manchester1, University of Leeds2, University of Washington3, Leeds Teaching Hospitals NHS Trust4, Université libre de Bruxelles5, Mater Dei Hospital6, Boston Children's Hospital7, University of Paris8, University of Göttingen9, Mount Sinai St. Luke's and Mount Sinai Roosevelt10, University of Barcelona11, Radboud University Nijmegen12, University of Oslo13, Royal Children's Hospital14, VU University Amsterdam15, Katholieke Universiteit Leuven16, University of São Paulo17, Rabin Medical Center18, University of British Columbia19, Technion – Israel Institute of Technology20, Baylor College of Medicine21, University of Melbourne22, Children's National Medical Center23, Ealing Hospital24, Imperial College London25
TL;DR: Mutations in SAMHD1 are described as the cause of Aicardi-Goutières syndrome at the AGS5 locus and data is presented to show that SAM HD1 may act as a negative regulator of the cell-intrinsic antiviral response.
Abstract: Aicardi-Goutieres syndrome is a mendelian mimic of congenital infection and also shows overlap with systemic lupus erythematosus at both a clinical and biochemical level The recent identification of mutations in TREX1 and genes encoding the RNASEH2 complex and studies of the function of TREX1 in DNA metabolism have defined a previously unknown mechanism for the initiation of autoimmunity by interferon-stimulatory nucleic acid Here we describe mutations in SAMHD1 as the cause of AGS at the AGS5 locus and present data to show that SAMHD1 may act as a negative regulator of the cell-intrinsic antiviral response
637 citations
••
Humanitas University1, University College Dublin2, Autonomous University of Madrid3, Cambridge University Hospitals NHS Foundation Trust4, Winterthur Museum, Garden and Library5, University of Basel6, Catholic University of the Sacred Heart7, Aarhus University Hospital8, University of Copenhagen9, Royal Liverpool University Hospital10, Aalborg University11, Mater Dei Hospital12, University of Bologna13, Barts Health NHS Trust14, Comenius University in Bratislava15, Sheba Medical Center16, University of Porto17, McMaster University18, Linköping University19, Seconda Università degli Studi di Napoli20, Katholieke Universiteit Leuven21, University of Padua22, Maastricht University Medical Centre23, Beaujon Hospital24, University of Zurich25, Imperial College London26
TL;DR: The present article addresses surgical management, including preoperative aspects and drug management before surgery, and provides technical advice for a variety of common clinical situations.
Abstract: This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.
563 citations
Authors
Showing all 1071 results
Name | H-index | Papers | Citations |
---|---|---|---|
John R. Petrie | 57 | 231 | 11008 |
Piergiorgio Cao | 44 | 147 | 5927 |
Serge Rozenberg | 43 | 230 | 6278 |
Margaret Rees | 43 | 185 | 5328 |
Annalisa Pantosti | 42 | 188 | 6531 |
William H. James | 41 | 363 | 6668 |
Irene Lambrinoudaki | 39 | 245 | 4829 |
Eliano Pio Navarese | 38 | 208 | 5875 |
Marco Gambacciani | 37 | 111 | 4790 |
Michael Borg | 36 | 112 | 5101 |
Karin Schenck-Gustafsson | 33 | 80 | 4089 |
Jane Somerville | 30 | 101 | 3210 |
Stephen Montefort | 29 | 123 | 9109 |
Gabriella Captur | 28 | 79 | 2645 |
Mark Brincat | 27 | 80 | 2888 |